
麻ç¹ã«é¢ããã¡ãã£ã¢ã®ãã¬ã€ããã¯ã¯COVIDã®ãã¬ã€ããã¯ãšãã䌌ãŠãã-ä»åã¯åäŸãé§
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã¡ãã£ã¢ã¯ã麻ç¹ããèŽåœçãªãç æ°ã§ãããšä¿¡ããããããšããŠããŸããããããMMRã¯ã¯ãã³ãéº»ç¹ææãããå®å šã§ãããšãã䞻匵ã¯ãäºå®ã«åºã¥ããŠããŸããã
éåã®æŽå²ã«ã¯ãã®æ±ºæã詊ãç¬éããããŸããå»çã®èªç±éåã«ãšã£ãŠãä»ãããã®ç¬éã§ãã
ç§ãã¡ã¯ãè£œè¬æ¥çãšãã®å©çã«åŸå±ããäž»æµã¡ãã£ã¢ã«ãã£ãŠæ¯æŽããã補è¬ç£æ¥è€åäœããã®å床ã®å šé¢çãªæ»æã®çã£åªäžã«ããŸãããã®æ»æã¯ã690åãã«èŠæš¡ã®ã¯ã¯ãã³ç£æ¥ãžã®å¿ èª å¿ã«åºã¥ããŠããŸãã
5幎åãç§ãã¡ã¯æ¿åºã倧æã¡ãã£ã¢ã補è¬äŒç€ŸãCOVID-19ã®ææãã£ã³ããŒã³ãä»çµã¿ãå®è¡ãããšãã«ç«ã¡åãããŸããããã®ãã£ã³ããŒã³ã¯åãæ¬ºçãæ€é²ã«åºã¥ããŠãããå ¬å ±ã®ææãå±éºã§èŽåœçãªå»çåœä»€ãç é¢ã®ãããã³ã«ã«å€ããä»ã§ãæ·±å»ãªå®³ãåŒãèµ·ããç¶ããŠããŸãã
COVID-19ã®äžçççœå®³ã®è¯ãç¹ã¯ïŒ
ããã¯ãæ°çŸäžäººã®äººã ã«ç²éã«ãã¹ããããã¯ã¯ãã³ãèŠå¶æ©é¢ã®å²æ ¢ãããããŠããã¹ãŠã®äººã«åããå»çã®å±éºæ§ãç®èŠããããããšã§ãã
ç§ãã¡ã®éåãççºçã«æé·ããã«ã€ããŠãè£œè¬æ¥çã«å¯Ÿããè åšãå¢ããŠããŸãã
ãã®åå¿ãšããŠãåãæŠè¡ãåã³äœ¿ãããŠããã®ãèŠåããããŸããä»åºŠã¯éº»ç¹ã§ããä»åºŠã¯ãåäŸãã¡ã補è¬äŒç€Ÿã®æŠç¥ã«ãããé§ãšãªã£ãŠããŸãã
Childrenâs Health DefenseïŒCHDïŒã¯ãCOVIDäžã匷ãç«ã¡ãç§ãã¡ã®äœ¿åœã«å¿ å®ã§ããç¶ããŸãããä»ãåæ§ã«åŒ·ãç«ã¡ç¶ããŠããŸãããã³ãããã¯ã®éãšåæ§ã«ãçå®ãã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããå»çã®èªç±ã«å¯Ÿããç§ãã¡ã®ã³ãããã¡ã³ãã¯å€ãããŸããã
è£œè¬æ¥çã麻ç¹ãå©çšããããšããäžãç§ãã¡ã®æãéèŠãªä»äºã¯ãã¯ã¯ãã³æ¥çã®åãæç Žããããšã§ã â ããã¯æ¥çã®æãä¿¡é Œã§ããããããŠå¿ å®ãªã¡ã¬ãã³ã§ããäž»æµã¡ãã£ã¢ãéããŠåºããããŠããŸãã
ã¡ãã£ã¢ã¯ã麻ç¹ããèŽåœçãªãç æ°ã§ãããšä¿¡ããããããšããŠããŸããããããMMRïŒéº»ç¹ã»ãããµã颚éªã»é¢šç¹ïŒã¯ã¯ãã³ãéº»ç¹ææãããå®å šã§ãããšãã䞻匵ã¯ãäºå®ã«åºã¥ããŠããŸããã
å®éã2000幎ãã2024幎ã®éã«CDCã«å ±åããã麻ç¹ã«é¢é£ããæ»è ã¯9人ã§ãããåæéäžãã¢ã¡ãªã«ã§ã¯MMRãŸãã¯MMRVã¯ã¯ãã³æ¥çš®åŸã«141äººãæ»äº¡ããŠãããMMRã¯ã¯ãã³ã麻ç¹ãããèŽåœçã§ããå¯èœæ§ã瀺åãããŠããŸãã
ã¡ãã£ã¢ã¯ãMMRã¯ã¯ãã³ããå§åçã«å®å šãã§ãããšãããæ±ºãŸãã®ãã¬ãŒãºãç¹°ãè¿ããŸãã
å®éãMMRã¯ã¯ãã³ã«ã¯æ·±å»ãªå¥åº·ãªã¹ã¯ã䌎ããŸããã¡ã«ã¯ã®MMRIIã®ããã±ãŒãžæ¿å ¥æžã«ã¯ããM-M-R IIã¯ã¯ãã³ã¯çºçæ§ãŸãã¯çªç¶å€ç°æ§ã®å¯èœæ§ããŸãã¯çæ®æ©èœãžã®åœ±é¿ã«ã€ããŠè©äŸ¡ãããŠããŸããããšèšèŒãããŠããŸãã
ç ç©¶ã«ããã°ãMMRã¯ã¯ãã³ã¯çºç±æ§ãããããã¢ããã£ã©ãã·ãŒãé«èçãè³çãè¡å°æ¿æžå°çãé¢ç¯çãè¡ç®¡çãåŒãèµ·ããããšãããã£ãŠããŸãã2004幎ãCDCã®ç ç©¶è ãã¡ã¯ãæééãã«æåã®MMRã¯ã¯ãã³ãæ¥çš®ããç·å ãã3æ³ä»¥éã«æ¥çš®ããç·å ããã67%é«ã確çã§èªéçãšèšºæãããããšãçºèŠããŸããã
ã¡ãã£ã¢ã¯ã麻ç¹ã«ã¯æå¹ãªæ²»çæ³ããªããšäž»åŒµããŸã â ãããã£ãŠãMMRã¯ã¯ãã³ã«ããäºé²ãå¯äžã®è§£æ±ºçã ãšã
å®éãCHDãå ±åãããšããã«ãããšã西ãããµã¹ã®å»åž«ãã¡ã¯ããããœãããšãã¿ãã³Aã§éº»ç¹ãæåè£ã«æ²»çããŠããŸããäžçä¿å¥æ©é¢ïŒWHOïŒããã¿ãã³Aãæšå¥šããŠããŸãã
ããããããã€ãã®ç é¢ãå»åž«ã¯ãéº»ç¹æ£è ã«å¯Ÿãããããœããã®äœ¿çšãæåŠããŠããŸãããããµã¹å·ã®ä¿å¥åœå±ã¯ãæ²»çæ³ãæ¯æãããã®å¹æã«ã€ããŠç é¢ã«ç¥ãããããæ²»çå»ããã®æé¡ãæåŠããŸããã
ãããã©ããã§èŠãããšããããŸãããïŒ
COVIDã®æã«ãåãæŠç¥ãèŠãŸãããã¡ãã£ã¢ã¯ãå ¬è¡è¡çåœå±ã®äž»åŒµãç¹°ãè¿ãããã¯ã¯ãã³ã ããç§ãã¡ãæãããšèšããªãããã€ãã«ã¡ã¯ãã³ãããããã·ã¯ãããã³ããããœããããã®ä»ã®COVIDã®éçåãæ»äº¡ãæžããããšãç¥ãããŠããæ²»çæ³ã®äœ¿çšãé¿ããããå²ç¬ããããã«ã¯å šé¢çã«å¶éããŸããã
å æã西ãããµã¹ã®6æ³ã®åäŸã麻ç¹ããå埩äžã«èºçãçºçããæ»äº¡ããŸãããã¡ãã£ã¢ã¯ããã®åäŸãã¯ã¯ãã³æ¥çš®ãåããŠããªãã£ããšããçç±ã§ãã¡ããã€ãå ±åäœã®äž¡èŠªãéé£ããŸããã
CHDã®ç§åŠããŒã ãšCHD.TVããŒã ãæããã«ãããšãããå°éå®¶ãåäŸã®å»çèšé²ãã¬ãã¥ãŒããçµæãã¡ãã£ã¢ã䞻匵ããããã«ãã®åäŸã麻ç¹ã§äº¡ããªã£ãã®ã§ã¯ãªããæ²åçãªå»çãã¹ãåå ã§äº¡ããªã£ãããšãããããŸããã
å®éãç é¢ã¯ãã®åäŸã®èºçãé©åã«èšºæããŠããŸãã â ã³ãã¥ããã£ææã«ããèºçã§ãé©åã«æ²»çãããã°åœã«é¢ããããšã¯ãããŸãããæ®å¿µãªãããå»åž«ãã¡ã¯ãã®èºçã®æ²»çã«å¿ èŠãªæšæºçãªæçç©è³ªã䜿çšããŸããã§ããã
CHDãæ»äº¡åå ãæ£ç¢ºã«æŽé²ããåŸããããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºãã¯ãã®6æ³ã®åäŸã麻ç¹ã§äº¡ããªã£ããšå ±ããç§ãã¡ããæ ¹æ ã®ãªã䞻匵ããããŠãããšéé£ããŸããã
å é±ã西ãããµã¹ã§äºäººç®ã®åäŸãæ»äº¡ããŸãããã¡ãã£ã¢ãšãããµã¹å·ã®ä¿å¥åœå±ã¯ãã®æ»ãã麻ç¹ã«ããèºäžå šããšå ±ããŸãããCHDã¯ããã®åäŸã®äž¡èŠªãšå ±ã«å»çèšé²ãåæããŠããŸãããããŠãç§ãã¡ãèŠã€ããããšãæ£ç¢ºã«å ±åããŸãã
ã¡ãã£ã¢ã¯ãCHDãšå»çèªç±éå â èšè ããåã¯ã¯ãã³è ããšåŒã¶ç§ãã¡ â ãã6æ³ã®åäŸã®æ²åçãªæ»ãæŠåšåããŠããããšéé£ããŠããŸããïŒå»çãã¹ã«ããæ»ã¯ã¢ã¡ãªã«ã§ã¯çãããããŸãããæ¯å¹Ž25äžäººä»¥äžã誀蚺ãäžé©åãªæ²»çã«ãã£ãŠæ»äº¡ãããšæšå®ãããŠãããããã¯æ»å ã®3äœãå ããŠããŸãïŒ
ã©ããªçç±ã§ãããåã©ãã®æ»äº¡ã¯å¿ãçãåºæ¥äºã§ãããããããã®å Žåãæ¬åœã®ãæŠåšã䜿ã£ãŠããè ãã¯èª°ãªã®ã§ããããïŒ
ããã¡ãã£ã¢ãæ¬åœã«åã©ããã¡ã®åœãå¿é ããŠããã®ã§ããã°ããªãCOVID-19ã¯ã¯ãã³ãMMRã¯ã¯ãã³ãCDCæšå¥šã®ä»ã®14çš®é¡ã®ã¯ã¯ãã³ã«ããåã©ããã¡ã®ã±ã¬ãæ»äº¡ã«ã€ããŠã®å ±éããªãã®ã§ããããïŒ
å æãCHDã¯ã1æ³ã®åã©ãã12æéåŸã«æ»äº¡ãããšããç¡æå³ãªäºä»¶ãå ±åããŸããããã®åã©ãã¯ããããã€ãã®å°å ç§å»ãäžåºŠã«6çš®é¡ã®ã¯ã¯ãã³ãæ¥çš®ãããåŸã§ããã
ãªããã®åã©ãã®æ»äº¡ãéé£ããèŠåºããåºãªãã£ãã®ã§ããããïŒ ãªãã远ãã€ãæ¥çš®ãã®å±éºæ§ã«ã€ããŠã®å ±éããªãã£ãã®ã§ããããïŒ
ã¡ãã£ã¢ãã匷倧ã§è²ªæ¬²ãªæ¥çãšãã®è°äŒã®æå ã«ãã£ãŠç¡å®ã®åã©ããã¡ã«åŒãèµ·ããããæšäºã«ã€ããŠæ²é»ããŠããéãCHDã¯ãããã®åã©ããã¡ã®éºç£ãå ±åããäºå®ãäŒãã芪ãç¬ç«ããæ å ±ã«åºã¥ããŠå»ç決å®ãè¡ãæš©å©ã䞻匵ããŠããŸãã
ãã®ææ°ã®å¥åº·èªç±éåã«å¯Ÿããæ»æã¯ãè£œè¬æ¥çã®æãã®èšŒã§ããç§ãã¡ã¯åå©ããŠããŸããè£œè¬æ¥çã¯ãããç¥ã£ãŠããŸãã
ç§ãã¡ã¯äºå®ããéãã€ããã¯ãããŸãããã¯ã¯ãã³ã¯æ·±å»ãªã±ã¬ãæ»äº¡ãåŒãèµ·ããããšããããŸããè£œè¬æ¥çãšã¡ãã£ã¢ã芪ãã¡ã®å¿ãšé ãåãæ»ãããã«æ°ãã«æŠããæãã§ããäžã§ãç§ãã¡ã¯æ±ºæã匷åãã䜿åœã«å¿ å®ã§ããç¶ããŸãã
ç§ãã¡ã®åã©ããã¡ã¯ãããã«ãµãããããã®ãåããã¹ãã§ãã